Zimmer Biomet Q1 net sales hit $1.97B amid declines in the Americas: 5 things to know

Spinal Tech

Zimmer Biomet reported net sales at $1.97 billion for the first quarter of 2019, a 0.7 percent increase.

 

Five things to know:

1. The company reported a 1.2 percent decline in sales in the Americas, hitting $1.2 billion. The company also reported a 6.6 percent sales decline in the EMEA and 1.4 percent sales increase in the Asia Pacific.

2. Knee sales were down 2.7 percent in the quarter, hitting $694 million overall. Knee sales in the Americas dropped nearly 2 percent to $409 million.

3. Hip sales were relatively flat in the Americas, dropping 0.3 percent to $247 million. Overall, hip sales were down 1.6 percent to $484 million.

4. Spine and craniomaxillofacial sales were flat at $183 million for the quarter.

5. In the first quarter, Zimmer Biomet paid down $110 million of debt and plans to use most of its $284 million cash flow to continue decreasing debt throughout the year.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like

Thank you so much for your interest in our content. Please register to access this complimentary archived content. By registering, you will receive our newsletter which can be opted out of at any time.

 

 

Already Registered? Click here to confirm.